Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Accounts Payables of $74.7 million in Q4 2025, down 5.57% quarter-over-quarter from $79.1 million in Q4 2024, and down 5.57% on a YoY basis from $79.1 million in Q4 2024.
Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $74.7 million for Q4 2025.
- In Q4 2025, Accounts Payables fell 5.57% year-over-year to $74.7 million; the TTM figure through Dec 2025 stood at $74.7 million (down 5.57% YoY), while the FY2025 annual figure was $74.7 million, down 5.57% from the prior year.
- Accounts Payables was $74.7 million for Q4 2025 at Curaleaf Holdings, down from $79.1 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $80.8 million in Q4 2022 to a low of $26.8 million in Q4 2021.
- Historically, Accounts Payables has averaged $68.1 million across 5 years, with a median of $79.1 million in 2024.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables sank 43.14% in 2021, then soared 202.0% in 2022.
- A 5-year view of Accounts Payables shows it stood at $26.8 million in 2021, then jumped by 202.0% to $80.8 million in 2022, then decreased by 1.82% to $79.3 million in 2023, then slipped by 0.24% to $79.1 million in 2024, then decreased by 5.57% to $74.7 million in 2025.
- The last three Accounts Payables figures came in at $74.7 million (Q4 2025), $79.1 million (Q4 2024), and $79.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.73 Mn |
| Dec 31, 2024 | 79.13 Mn |
| Dec 31, 2023 | 79.32 Mn |
| Dec 31, 2022 | 80.79 Mn |
| Dec 31, 2021 | 26.75 Mn |
| Dec 31, 2020 | 47.04 Mn |
| Dec 31, 2019 | 12.74 Mn |